Frederick National Laboratory for Cancer Research, Frederick, MD; Molecular Imaging Branch, National Cancer Institute, Bethesda MD.
Contractor to Frederick National Laboratory for Cancer Research, Leidos biodical Research, Inc., Frederick, MD; Molecular Imaging Branch, National Cancer Institute, Bethesda MD.
Semin Nucl Med. 2022 May;52(3):382-402. doi: 10.1053/j.semnuclmed.2022.02.002. Epub 2022 Mar 18.
The classical intent of PET imaging is to obtain the most accurate estimate of the amount of positron-emitting radiotracer in the smallest possible volume element located anywhere in the imaging subject at any time using the least amount of radioactivity. Reaching this goal, however, is confounded by an enormous array of interlinked technical issues that limit imaging system performance. As a result, advances in PET, human or animal, are the result of cumulative innovations across each of the component elements of PET, from data acquisition to image analysis. In the report that follows, we trace several of these advances across the imaging process with a focus on small animal PET.
正电子发射断层成像(PET)的经典目的是使用尽可能少的放射性物质,在任何时间、任何位置,从成像对象的最小可能体积元素中,获得正电子放射性示踪剂数量的最准确估计。然而,要达到这一目标,就会受到大量相互关联的技术问题的困扰,这些问题限制了成像系统的性能。因此,无论是在人体还是动物 PET 上,技术的进步都是 PET 的各个组成部分(从数据采集到图像分析)的累积创新的结果。在接下来的报告中,我们将重点关注小动物 PET,沿着成像过程追踪其中的一些进展。